Murayama Daisuke, Hashizume Toko, Hirano Ryosuke, Azuhata Koji, Shimojo Hisashi, Ito Nobuo, Mishima Osamu
Department of Breast and Thyroid Surgery, Aizawa Hospital, Matsumoto, Nagano, Japan.
Department of Pathology, Aizawa Hospital, Matsumoto, Nagano, Japan.
J Surg Case Rep. 2022 Dec 30;2022(12):rjac599. doi: 10.1093/jscr/rjac599. eCollection 2022 Dec.
We herein report the case of a 48-year-old man diagnosed with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL, Stage IA) and papillary thyroid carcinoma (PTC, Stage I). Total thyroidectomy, left modified neck dissection and biopsy of the right cervical lymph node were performed. Postoperatively, NLPHL treatment was prioritized, and external radiation (30.6 Gy) was applied to the right neck. PTC was considered a high-risk category for recurrence due to extranodal invasion of lymph node metastasis, and radioactive iodine therapy (ablative dose, 1110 MBq) was administered. Both PTC and NLPHL showed no recurrence 18 months after surgery.
我们在此报告一例48岁男性患者，其被诊断为结节性淋巴细胞为主型霍奇金淋巴瘤（NLPHL，IA期）和甲状腺乳头状癌（PTC，I期）。进行了全甲状腺切除术、左侧改良颈淋巴结清扫术以及右侧颈部淋巴结活检。术后，优先对NLPHL进行治疗，对右侧颈部进行了外照射（30.6 Gy）。由于淋巴结转移的结外侵犯，PTC被认为是复发的高危类型，并给予了放射性碘治疗（消融剂量，1110 MBq）。术后18个月，PTC和NLPHL均未出现复发。
